Current Report · Items 5.02 · 8-K
Embrace Change Acquisition Corp.
EMCGFOTCEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On December 25, 2025, Embrace Change Acquisition Corp.…
Company context
Current securities
Recent company filings
- Entry into a Material Definitive AgreementSep 14, 2026
- NT 10-Q filingAug 12, 2026
- Entry into a Material Definitive Agreement · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security Holders · Other EventsAug 12, 2026
- DEF 14A filingJul 21, 2026
- PRE 14A filingJul 8, 2026
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of
Certain Officers.
On
December 25, 2025, Embrace Change Acquisition Corp. (the “Company”) received a written notice from Jingyu Wang that he resigned
from his position as the Company’s Chief Executive Officer, pending on the approval from the Company’s board of directors
(the “Board”). Mr. Wang’s decision to resign was not due to any disagreements with the Company on any matter relating
to the Company’s operations, policies, or practice.
On
December 26, 2025, the Board approved the resignation of Jingyu Wang from the Company’s Chief Executive Officer, and appointed
Zheng Yuan, the Company’s Chief Financial Officer, as the Company’s Chief Executive Officer, in addition to her Chief Financial
Officer position.
Jingyu
Wang has been the Company’s director since December 2022 and was the Company’s Chief Executive Officer from December 2022
to December 2025. Mr. Wang served as an advisor to the Company in connection with its initial public offering and public disclosures
from September 2021 until his appointment as Chief Executive Officer. From October 2024, Mr. Wang has been a director and the secretary
of the board of Hangzhou Tangji Medical Technology Co., Ltd, overseeing capital markets operations and managing investor relations. From
June 2015 to September 2021, Mr. Wang served as the secretary of the board for 36Kr Holdings Inc., a company listed on Nasdaq (Nasdaq:
KRKR), for which he coordinated the Company’s public disclosures. Mr. Wang received his bachelor’s degree in laws from China
University of Political Science and Law in 2012.
Zheng
Yuan has been the Company’s Chief Financial Officer and a director since March 2021. From July 2024, Ms. Yuan has also been a weekend
teacher at San Diego Huaxia Chinese School teaching Mandarin Chinese. From June 2017 until August 2021, Ms. Yuan was the Acting as CFO
and Administrative Director of Ningbo Super fan Culture Media Co., Ltd., a joint stock limited company. From October 2010 until March
2016, she was the Vice President of International Banking for Bank of Beijing Co., Ltd. She received master’s and bachelor’s
degrees from Tianjin University of Finance and Economics.